Given the conflicting reported significance for TXNIP in various tumors and the increased expression identified in our outlier analysis of in vitro spheroids, we examined if TXNIP was prognostic in clinical ovarian cancer patient samples. The gene discussed is TXNIP; the disease is ovarian cancer.